blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2978440

EP2978440 - TREATING FIBROSIS BY INHIBITING TL1A AND DIAGNOSING FIBROSIS BY DETECTING IL31RA [Right-click to bookmark this link]
Former [2016/05]TREATING FIBROSIS AND INFLAMMATION BY INHIBITING TL1A
[2019/20]
StatusPatent revoked
Status updated on  29.07.2022
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  30.08.2019
FormerGrant of patent is intended
Status updated on  25.04.2019
FormerExamination is in progress
Status updated on  17.11.2017
Most recent event   Tooltip29.07.2022Revocation of patentpublished on 31.08.2022  [2022/35]
Applicant(s)For all designated states
Cedars-Sinai Medical Center
8700 Beverly Boulevard
Los Angeles, CA 90048 / US
[2016/05]
Inventor(s)01 / SHIH, David Q.
3816 Sky View Lane
La Crescenta, California 91214 / US
02 / TARGAN, Stephan R.
240 22nd Street
Santa Monica, California 90402 / US
03 / LI, Dalin
20550 Camelback Drive
Walnut, California 91789 / US
04 / BILSBOROUGH, Janine
390 Pellburne Court
Simi Valley, California 93065 / US
 [2016/05]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[N/P]
Former [2019/40]HGF Limited
4th Floor
Merchant Exchange
17-19 Whitworth Street West
Manchester M1 5WG / GB
Former [2016/05]Banford, Paul Clifford, et al
HGF Limited
4th Floor, Merchant Exchange
17-19 Whitworth Street West
Manchester M1 5WG / GB
Application number, filing date14773989.027.03.2014
[2016/05]
WO2014US32054
Priority number, dateUS201361805806P27.03.2013         Original published format: US 201361805806 P
US201361872020P30.08.2013         Original published format: US 201361872020 P
[2016/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014160883
Date:02.10.2014
Language:EN
[2014/40]
Type: A1 Application with search report 
No.:EP2978440
Date:03.02.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 02.10.2014 takes the place of the publication of the European patent application.
[2016/05]
Type: B1 Patent specification 
No.:EP2978440
Date:02.10.2019
Language:EN
[2019/40]
Search report(s)International search report - published on:US02.10.2014
(Supplementary) European search report - dispatched on:EP19.12.2016
ClassificationIPC:C12Q1/6883, A61K39/00, C07K16/28, A61P1/00, G01N33/53
[2019/21]
CPC:
A61P1/00 (EP,KR); C07K16/2875 (EP,KR,US); C07K16/2866 (US);
A61K39/3955 (US); A61P1/04 (EP); A61P29/00 (EP);
A61P43/00 (EP); C07K16/241 (US); C07K16/2878 (KR,US);
C12N15/1138 (US); C12Q1/6883 (EP,KR,US); G01N33/6869 (US);
G01N33/6893 (KR); A61K2039/505 (KR); A61K45/06 (US);
C07K16/24 (US); C07K2317/76 (US); C12N2320/30 (US);
C12Q2600/112 (US); C12Q2600/156 (EP,US); C12Q2600/158 (US);
G01N2333/7155 (US); G01N2800/065 (KR,US); G01N2800/10 (US) (-)
Former IPC [2019/20]C12Q1/68, A61K39/00, C07K16/28, A61P1/00, G01N33/53
Former IPC [2017/03]A61K38/12, A61K38/16, C12Q1/68, C07K16/28
Former IPC [2016/05]A61K38/12, A61K38/16, C12Q1/68
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/05]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:BEHANDLUNG VON FIBROSE DURCH TL1A-HEMMUNG UND DIAGNOSE VON FIBROSE DURCH IL31RA-NACHWEIS[2019/20]
English:TREATING FIBROSIS BY INHIBITING TL1A AND DIAGNOSING FIBROSIS BY DETECTING IL31RA[2019/20]
French:TRAITEMENT DE LA FIBROSE PAR INHIBITION DE TL1A ET DIAGNOSTIC DE FIBROSE PAR DETECTION DE LI31RA[2019/20]
Former [2016/05]BEHANDLUNG VON FIBROSE UND ENTZÜNDUNGEN DURCH TL1A-HEMMUNG
Former [2016/05]TREATING FIBROSIS AND INFLAMMATION BY INHIBITING TL1A
Former [2016/05]TRAITEMENT DE LA FIBROSE ET DE L'INFLAMMATION PAR INHIBITION DE TL1A
Entry into regional phase29.09.2015National basic fee paid 
29.09.2015Search fee paid 
29.09.2015Designation fee(s) paid 
29.09.2015Examination fee paid 
Examination procedure29.09.2015Examination requested  [2016/05]
17.07.2017Amendment by applicant (claims and/or description)
17.11.2017Despatch of a communication from the examining division (Time limit: M06)
25.05.2018Reply to a communication from the examining division
10.08.2018Despatch of a communication from the examining division (Time limit: M04)
11.12.2018Reply to a communication from the examining division
26.04.2019Communication of intention to grant the patent
19.08.2019Fee for grant paid
19.08.2019Fee for publishing/printing paid
19.08.2019Receipt of the translation of the claim(s)
Divisional application(s)EP19199149.6  / EP3639841
EP23188250.7  / EP4285988
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.11.2017
Opposition(s)Opponent(s)01  01.07.2020    ADMISSIBLE
Strawman Limited
Orchard Lea
Horns Lane
Combe, Witney
Oxfordshire OX29 8NH / GB
Opponent's representative
D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
 [N/P]
Former [2020/32]
Opponent(s)01  01.07.2020    ADMISSIBLE
Strawman Limited
Orchard Lea
Horns Lane
Combe, Witney
Oxfordshire OX29 8NH / GB
Opponent's representative
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
14.07.2020Invitation to proprietor to file observations on the notice of opposition
23.11.2020Reply of patent proprietor to notice(s) of opposition
25.03.2022Date of oral proceedings
25.03.2022Legal effect of revocation of patent [2022/35]
14.04.2022Despatch of minutes of oral proceedings
14.04.2022Despatch of communication that the patent will be revoked
Fees paidRenewal fee
31.03.2016Renewal fee patent year 03
27.03.2017Renewal fee patent year 04
27.03.2018Renewal fee patent year 05
27.03.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.03.2014
AL02.10.2019
AT02.10.2019
CY02.10.2019
CZ02.10.2019
DK02.10.2019
EE02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
IT02.10.2019
LT02.10.2019
LV02.10.2019
MC02.10.2019
MK02.10.2019
MT02.10.2019
NL02.10.2019
PL02.10.2019
RO02.10.2019
RS02.10.2019
SE02.10.2019
SI02.10.2019
SK02.10.2019
SM02.10.2019
TR02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
IS02.02.2020
PT03.02.2020
IE27.03.2020
LU27.03.2020
BE31.03.2020
[2022/32]
Former [2022/27]HU27.03.2014
AL02.10.2019
AT02.10.2019
CY02.10.2019
CZ02.10.2019
DK02.10.2019
EE02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
IT02.10.2019
LT02.10.2019
LV02.10.2019
MC02.10.2019
MT02.10.2019
NL02.10.2019
PL02.10.2019
RO02.10.2019
RS02.10.2019
SE02.10.2019
SI02.10.2019
SK02.10.2019
SM02.10.2019
TR02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
IS02.02.2020
PT03.02.2020
IE27.03.2020
LU27.03.2020
BE31.03.2020
Former [2021/12]AL02.10.2019
AT02.10.2019
CZ02.10.2019
DK02.10.2019
EE02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
IT02.10.2019
LT02.10.2019
LV02.10.2019
MC02.10.2019
NL02.10.2019
PL02.10.2019
RO02.10.2019
RS02.10.2019
SE02.10.2019
SI02.10.2019
SK02.10.2019
SM02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
IS02.02.2020
PT03.02.2020
IE27.03.2020
LU27.03.2020
BE31.03.2020
Former [2021/08]AL02.10.2019
AT02.10.2019
CZ02.10.2019
DK02.10.2019
EE02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
IT02.10.2019
LT02.10.2019
LV02.10.2019
MC02.10.2019
NL02.10.2019
PL02.10.2019
RO02.10.2019
RS02.10.2019
SE02.10.2019
SI02.10.2019
SK02.10.2019
SM02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
IS02.02.2020
PT03.02.2020
IE27.03.2020
LU27.03.2020
Former [2021/04]AL02.10.2019
AT02.10.2019
CZ02.10.2019
DK02.10.2019
EE02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
IT02.10.2019
LT02.10.2019
LV02.10.2019
MC02.10.2019
NL02.10.2019
PL02.10.2019
RO02.10.2019
RS02.10.2019
SE02.10.2019
SI02.10.2019
SK02.10.2019
SM02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
IS02.02.2020
PT03.02.2020
LU27.03.2020
Former [2020/50]AL02.10.2019
AT02.10.2019
CZ02.10.2019
DK02.10.2019
EE02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
IT02.10.2019
LT02.10.2019
LV02.10.2019
MC02.10.2019
NL02.10.2019
PL02.10.2019
RO02.10.2019
RS02.10.2019
SE02.10.2019
SI02.10.2019
SK02.10.2019
SM02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
IS02.02.2020
PT03.02.2020
Former [2020/38]AL02.10.2019
AT02.10.2019
CZ02.10.2019
DK02.10.2019
EE02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
IT02.10.2019
LT02.10.2019
LV02.10.2019
NL02.10.2019
PL02.10.2019
RO02.10.2019
RS02.10.2019
SE02.10.2019
SK02.10.2019
SM02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
IS02.02.2020
PT03.02.2020
Former [2020/37]AL02.10.2019
AT02.10.2019
CZ02.10.2019
DK02.10.2019
EE02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
LT02.10.2019
LV02.10.2019
NL02.10.2019
PL02.10.2019
RO02.10.2019
RS02.10.2019
SE02.10.2019
SK02.10.2019
SM02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
IS02.02.2020
PT03.02.2020
Former [2020/36]AL02.10.2019
AT02.10.2019
CZ02.10.2019
DK02.10.2019
EE02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
LT02.10.2019
LV02.10.2019
NL02.10.2019
PL02.10.2019
RO02.10.2019
RS02.10.2019
SE02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
IS02.02.2020
PT03.02.2020
Former [2020/35]AL02.10.2019
AT02.10.2019
CZ02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
LT02.10.2019
LV02.10.2019
NL02.10.2019
PL02.10.2019
RO02.10.2019
RS02.10.2019
SE02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
PT03.02.2020
IS24.02.2020
Former [2020/32]AL02.10.2019
AT02.10.2019
CZ02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
LT02.10.2019
LV02.10.2019
NL02.10.2019
PL02.10.2019
RS02.10.2019
SE02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
PT03.02.2020
IS24.02.2020
Former [2020/25]AT02.10.2019
CZ02.10.2019
ES02.10.2019
FI02.10.2019
HR02.10.2019
LT02.10.2019
LV02.10.2019
NL02.10.2019
PL02.10.2019
RS02.10.2019
SE02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
PT03.02.2020
IS24.02.2020
Former [2020/24]AT02.10.2019
ES02.10.2019
FI02.10.2019
LT02.10.2019
LV02.10.2019
NL02.10.2019
PL02.10.2019
SE02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
PT03.02.2020
IS24.02.2020
Former [2020/23]AT02.10.2019
ES02.10.2019
FI02.10.2019
LT02.10.2019
LV02.10.2019
NL02.10.2019
PL02.10.2019
SE02.10.2019
BG02.01.2020
NO02.01.2020
GR03.01.2020
PT03.02.2020
Former [2020/22]FI02.10.2019
LT02.10.2019
NL02.10.2019
SE02.10.2019
BG02.01.2020
NO02.01.2020
PT03.02.2020
Former [2020/21]NL02.10.2019
NO02.01.2020
Former [2020/20]NL02.10.2019
Cited inInternational search[X]US2009317388  (BURKLY LINDA [US], et al);
 [Y]US7708996  (YU GUO-LIANG [US], et al);
 [X]US8017122  (SIADAK ANTHONY W [US], et al);
 [A]US2012079611  (SHIH DAVID Q [US], et al);
 [X]US8263743  (SMITH RODGER [US], et al);
 [X]US2012315282  (BEDINGER DANIEL [US], et al);
OppositionUS2012079611
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.